Skip to main content

Viveve Medical, Inc. (VIVE)

NASDAQ: VIVE · Delayed Price · USD
2.34
+0.06 (2.63%)
After-hours:Oct 21, 2021 6:09 PM EDT
2.28
0.00 (0.00%)
At close: Oct 21, 4:00 PM
Market Cap24.06M
Revenue (ttm)6.58M
Net Income (ttm)-22.71M
Shares Out10.50M
EPS (ttm)-3.93
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume116,347
Open2.27
Previous Close2.28
Day's Range2.27 - 2.37
52-Week Range2.07 - 6.78
Beta0.66
AnalystsStrong Buy
Price Target9.63 (+322.4%)
Est. Earnings DateNov 11, 2021

About VIVE

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Mi...

IndustryHealth Care Equipment & Supplies
Founded2005
Employees42
Stock ExchangeNASDAQ
Ticker SymbolVIVE
Full Company Profile

Financial Performance

In 2020, Viveve Medical's revenue was $5.48 million, a decrease of -16.57% compared to the previous year's $6.57 million. Losses were -$21.92 million, -48.47% less than in 2019.

Financial Statements

Analyst Forecast

According to one analyst, the rating for Viveve Medical stock is "Strong Buy" and the 12-month stock price forecast is 9.63.

Price Target
$9.63
(322.37% upside)
Analyst Consensus: Strong Buy

News

Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia

Patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / September 23, 2021 / Viveve Medical, Inc. (NASDAQ:VI...

4 weeks ago - Accesswire

Are Biotech Penny Stocks Worth Buying? Check These 3 Out

Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other symbols:AIKICLVS
1 month ago - PennyStocks

Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive o...

1 month ago - Accesswire

Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Total revenue of $1.7M reported for Q2 Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarter Pivotal SUI PURSUIT trial enrollment on-track for comple...

2 months ago - Accesswire

Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Up...

ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its second quarter ...

2 months ago - Accesswire

Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent

ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual Property...

2 months ago - Accesswire

Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure

New code approved by American Medical Association and supported by key medical societies Long-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment for...

3 months ago - Accesswire

Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference

ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive office...

3 months ago - Accesswire

Viveve Announces Issuance of New Device and Methods Patent in U.S.

ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Tradem...

4 months ago - Accesswire

Viveve Announces Adjournment of Annual Meeting

Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), ...

4 months ago - Accesswire

Recap: Viveve Medical Q1 Earnings

Shares of Viveve Medical (NASDAQ:VIVE) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 2.44% year over year to ($0.80), which missed...

5 months ago - Benzinga

Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update

Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets E...

5 months ago - Accesswire

Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update

ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2021...

5 months ago - Accesswire

Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan

ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Taiwan Intellectual Property Of...

6 months ago - Accesswire

Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update

Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Vive...

7 months ago - Accesswire

Viveve to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference

ENGLEWOOD, CO / ACCESSWIRE / March 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive offic...

7 months ago - Accesswire

Huge Upside Potential in 5 Stocks Trading Under $10

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other symbols:CVECNTYNMTR
8 months ago - 24/7 Wall Street

2 Falling Knives to Catch

Wall Street recommends buying shares of CHF Solutions Inc (NASDAQ:CHFS) and Viveve Medical Inc (NASDAQ:VIVE), which sounds quite unexpected since these two stocks performed very poorly over the prior 52...

9 months ago - GuruFocus

Viveve Announces Pricing of Upsized $24 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / January 14, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the pricing of an upsized ...

9 months ago - Accesswire

Viveve Regains Compliance with NASDAQ Continued Listing Rules

ENGLEWOOD, CO / ACCESSWIRE /  December 17, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it received notice from The NA...

10 months ago - Accesswire

Viveve Medical's (VIVE) CEO Scott Durbin on Q3 2020 Results - Earnings Call Transcript

Viveve Medical's (VIVE) CEO Scott Durbin on Q3 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Viveve Medical News: Why VIVE Stock Is Rocketing 48% Today

Viveve Medical (VIVE) news for Tuesday includes positive results from a recent feasibility study pushing VIVE stock higher. The post Viveve Medical News: Why VIVE Stock Is Rocketing 48% Today appeared f...

1 year ago - InvestorPlace

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2020 Results - Earnings Call Transcript

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Bet on Rising Price-to-Earnings With 5 Top Stocks

Inside the top-ranked stocks that have been exhibiting rising price-to-earnings ratios.

Other symbols:AVGRBLRXVCNX
1 year ago - Zacks Investment Research

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha